chartexchange

NVO
Novo-Nordisk A/S
stockNYSEADR

Market OpenOct 8, 2026 2:21:00 PM EDT
37.81USD-1.176%(-0.45)7,437,225
37.80Bid37.81Ask0.01Spread
Pre-marketOct 8, 2026 9:29:30 AM EDT
37.81USD-1.176%(-0.45)
Loading…
Loading…
166.91B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$38.26
Beta
1.04
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$43.96
SMA 200
$45.50
Avg. Vol 10D
14.15M
Avg. Vol 30D
13.23M
Avg. Vol 90D
12.72M
Relative Vol
0.53
3.17B
26,339,706
0.3000%
10,000,000
13,000
Nov 4, 2026 (27d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
NVO Profile

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.

NVO Performance
PeriodPriceDateChangeBeta
1W37.402026-10-01+1.10%-1.989
1M45.162026-09-08-16.27%-0.443
3M48.892026-07-08-22.66%-0.287
6M37.612026-04-08+0.53%0.180
1Y59.612025-10-08-36.57%1.038
2Y117.202024-10-08-67.74%—
5Y49.192021-10-08-23.14%0.672
NVO Stock Summary

Novo-Nordisk A/S (NYSE:NVO) stock price today is $37.81, and today's volume is 7,036,577. NVO is down 1.176% today. The 30 day average volume is 13.23M. NVO market cap is $166.91B with 4.41B shares outstanding.